ReGelTec
Baltimore, US · Founded 2018 · 2 known investors
ReGelTec develops HYDRAFIL, an injectable hydrogel implant that is heated to a liquid, injected into the nucleus of an intervertebral disc with a needle, and cools to a solid that mimics the natural disc's biomechanical properties. The technology targets degenerative disc disease and chronic low back pain.
BiotechHealthtechMedical Devices
Founders & leadership
AL
Anthony LowmanDirector
MC
Mark CollinsExecutive Officer
MA
Moss AmerDirector
WN
William NilandExecutive Officer, Director
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$4MraisedJan 2021 · 30 investors · BiotechnologyRule 506(b)
▶$4MraisedJan 2021 · 30 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Anthony LowmanDirector
- William NilandExecutive Officer, Director
- Mark CollinsExecutive Officer
- Offering amount
- $4M
- Amount sold
- $4M
- First sale
- Dec 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$2MraisedNov 2018 · 17 investors · BiotechnologyRule 506(b)
▶$2MraisedNov 2018 · 17 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Anthony LowmanDirector
- Mark CollinsExecutive Officer
- Moss AmerDirector
- William NilandExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $2M
- First sale
- Sep 2018
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.